Did you miss the fantastic Accuray Symposium? Don’t worry you can watch the recording here.
Stereotactic Body Radiation Therapy for Oligometastatic Disease: Benefits and Limitations
Nicholas van As, M.D. | Medical Director and Consultant Clinical Oncologist of The Royal Marsden NHS Foundation Trust and Professor in Precision Prostate Radiotherapy at The Institute of Cancer Research, London, UK | ESTRO 2024
Oligometastatic Disease: State of the Art
Umberto Ricardi, M.D. | Full Professor of Radiation Oncology and Chairman of the Radiation Oncology Department, University of Turin, Turin, Italy | ESTRO 2024
The Evolving Oligometastatic Paradigm: Clinical, Pathological, and Radiographic Perspectives
Piet Ost, M.D., Ph.D. | Associate Professor at Ghent University, Ghent and Radiation Oncologist at the Iridium Network, Antwerp, Belgium | ESTRO 2024
Integration of Systemic and Targeted Therapies in the Management of Oligometastatic SBRT
Barbara Jereczek-Fossa, M.D., Ph.D. | Full Professor of Radiation Oncology at the Department of Oncology and Hemato-oncology at the University of Milan and Head of the Department of Radiation Oncology at the European Institute of Oncology IRCCS (IEO), Milan, Italy | ESTRO 2024
